Improving immunogenicity of poultry vaccines by use of molecular adjuvants

References

• Akira, S. 2000. “The Role of IL-18 in Innate Immunity.” Current Opinion in Immunology 12 (1): 59–63. doi:10.1016/S0952-7915(99)00051-5.
   Google Scholar
• Awate S, Babiuk L A, Mutwiri G. (2013). Mechanisms of action of adjuvants. Front Immunol, 4: 114. doi: 10.3389/fimmu.2013.00114
   PubMed Web of Science ®Google Scholar
• Barber, M. R. W., J. R. Aldridge, R. G. Webster, and K. E. Magor. 2010. “Association of RIG-I with Innate Immunity of Ducks to Influenza.” Proceedings of the National Academy of Sciences of the United States of America 107 (13): 5913–5918. doi:10.1073/pnas.1001755107.
   Web of Science ®Google Scholar
• Barber, M. R. W., J. R. Aldridge, X. Fleming-Canepa, Y. D. Wang, R. G. Webster, and K. E. Magor. 2013. “Identification of Avian RIG-I Responsive Genes during Influenza Infection.” Molecular Immunology 54 (1): 89–97. doi:10.1016/j.molimm.2012.10.038.
   Google Scholar
• Bastola, R., G. Noh, T. Keum, S. Bashyal, J. E. Seo, J. Choi, O. Yeonsu, Y. S. Cho, and S. Lee. 2017. “Vaccine Adjuvants: Smart Components to Boost the Immune System.” Archives of Pharmacal Research 40 (11): 1238–1248. Pharmaceutical Society of Korea. doi:10.1007/s12272-017-0969-z.
   PubMed Web of Science ®Google Scholar
• Bengtsson, L., B. M. Karin, and A. D. Osterhaus. 2011. “ISCOM Technology-Based Matrix MTM Adjuvant: Success in Future Vaccines Relies on Formulation.” Expert Review of Vaccines 10 (4): 401–403. doi:10.1586/erv.11.25.
   Google Scholar
• Brownlie, R., J. Zhu, G. K. Brenda Allan, L. A. Mutwiri, A. P. Babiuk, and P. Griebel. 2009. “Chicken TLR21 Acts as a Functional Homologue to Mammalian TLR9 in the Recognition of CpG Oligodeoxynucleotides.” Molecular Immunology 46 (15): 3163–3170. doi:10.1016/j.molimm.2009.06.002.
   PubMed Web of Science ®Google Scholar
• Burakova, Y., R. Madera, S. McVey, J. R. Schlup, and J. Shi. 2018. “Adjuvants for Animal Vaccines.” Viral Immunology 31 (1): 11–22. doi:10.1089/vim.2017.0049.
   PubMed Web of Science ®Google Scholar
• Chaudhari, A. A., W. H. Kim, and H. S. Lillehoj. 2018. “Interleukin-4 (IL-4) May Regulate Alternative Activation of Macrophage-like Cells in Chickens: A Sequential Study Using Novel and Specific Neutralizing Monoclonal Antibodies against Chicken IL-4.” Veterinary Immunology and Immunopathology 205 (October): 72–82. Elsevier. doi:10.1016/j.vetimm.2018.10.011.
   Google Scholar
• Chen, J., Z. Y. Li, E. Petersen, W. G. Liu, and X. Q. Zhu. 2016. “Co-Administration of Interleukins 7 and 15 with DNA Vaccine Improves Protective Immunity against Toxoplasma Gondii.” Experimental Parasitology 162: 18–23. Elsevier Inc. doi:10.1016/j.exppara.2015.12.013.
   PubMed Web of Science ®Google Scholar
• Cheng, Y., Q. Huang, J. Wenhui, D. Bin, F. Qiang, A. Huiting, L. Jing, et al. 2015. “Muscovy Duck Retinoic Acid-Induced Gene I (MdRIG-I) Functions in Innate Immunity against H9N2 Avian Influenza Viruses (AIV) Infections.” Veterinary Immunology and Immunopathology 163 (3–4): 183–193. doi:10.1016/j.vetimm.2014.12.009.
   Google Scholar
• Dai, M., W. Siyu, M. Feng, S. Feng, C. Sun, D. Bai, G. Mingzhu, M. Liao, and W. Cao. 2016. “Recombinant Chicken Interferon-Alpha Inhibits the Replication of Exogenous Avian Leukosis Virus (ALV) in DF-1 Cells.” Molecular Immunology 76: 62–69. Elsevier Ltd. doi:10.1016/j.molimm.2016.06.012.
   Google Scholar
• Degen, W. G. J., N. van Daal, H. I. van Zuilekom, J. Burnside, and V. E. J. C. Schijns. 2004. “Identification and Molecular Cloning of Functional Chicken IL-12.” The Journal of Immunology 172 (7): 4371–4380. doi:10.4049/jimmunol.172.7.4371.
   Google Scholar
• Digby, M. R., and J. W. Lowenthal. 1995. “Cloning and Expression of the Chicken Interferon-γ Gene.” Journal of Interferon and Cytokine Research 15 (11): 939–945. doi:10.1089/jir.1995.15.939.
   Google Scholar
• Dumitriu, I. E., P. Baruah, B. Valentinis, R. E. Voll, M. Herrmann, P. P. Nawroth, B. Arnold, M. E. Bianchi, A. A. Manfredi, and P. Rovere-Querini. 2005. “Release of High Mobility Group Box 1 by Dendritic Cells Controls T Cell Activation via the Receptor for Advanced Glycation End Products.” The Journal of Immunology 174 (12): 7506–7515. doi:10.4049/jimmunol.174.12.7506.
   PubMed Web of Science ®Google Scholar
• Ebrahimi, M. M., S. Shahsavandi, and P. Shayan. 2019. “TIR-TLR7 as a Molecular Adjuvant: Simultaneous Enhancing Humoral and Cell-Mediated Immune Responses against Inactivated Infectious Bursal Disease Virus.” Viral Immunology 32 (6): 252–257. doi:10.1089/vim.2018.0158.
   Google Scholar
• Espinosa, R., D. Tago, and N. Treich. 2020. “Infectious Diseases and Meat Production.” Environmental and Resource Economics 76 (4): 1019–1044. Springer Netherlands. doi:10.1007/s10640-020-00484-3.
   PubMed Web of Science ®Google Scholar
• Gerdts, V. 2015. “Adjuvants for Veterinary Vaccines – Types and Modes of Action.” Berliner Und Munchener Tierarztliche Wochenschrift 128 (11–12): 456–463. doi:10.2376/0005-9366-128-456.
   Google Scholar
• Göbel, T. W., K. Schneider, B. Schaerer, I. Mejri, F. Puehler, S. Weigend, P. Staeheli, and B. Kaspers. 2003. “IL-18 Stimulates the Proliferation and IFN-γ Release of CD4 + T Cells in the Chicken: Conservation of a Th1-Like System in a Nonmammalian Species .” The Journal of Immunology 171 (4): 1809–1815. doi:10.4049/jimmunol.171.4.1809.
   Google Scholar
• Goossens, K. E., A. C. Ward, J. W. Lowenthal, and A. G. D. Bean. 2013. “Chicken Interferons, Their Receptors and Interferon-Stimulated Genes.” Developmental and Comparative Immunology 41 (3): 370–376. Elsevier Ltd. doi:10.1016/j.dci.2013.05.020.
   Google Scholar
• Gulce-Iz, S., and P. Saglam-Metiner. 2019. “Current State of the Art in DNA Vaccine Delivery and Molecular Adjuvants: Bcl-XL Anti-Apoptotic Protein as a Molecular Adjuvant.” Immune Response Activation and Immunomodulation. doi:10.5772/intechopen.82203.
   Google Scholar
• Gupta, A., and S. R. Chaphalkar. 2015. “Vaccine Adjuvants: The Current Necessity of Life.” Shiraz E Medical Journal 16: 7. doi:10.17795/semj28061.
   Google Scholar
• Haarlem, V., D. A. P. J. S. van Kooten, L. Rothwell, P. Kaiser, and L. Vervelde. 2009. “Characterisation and Expression Analysis of the Chicken Interleukin-7 Receptor Alpha Chain.” Developmental and Comparative Immunology 33 (9): 1018–1026. doi:10.1016/j.dci.2009.05.001.
   Google Scholar
• Heegaard, P. M. H., L. Dedieu, N. Johnson, M.-F. Le Potier, M. Mockey, F. Mutinelli, T. Vahlenkamp, M. Vascellari, and N. S. Sørensen. 2011. “Adjuvants and Delivery Systems in Veterinary Vaccinology: Current State and Future Developments.” Archives of Virology 156 (2): 183–202. doi:10.1007/s00705-010-0863-1.
   PubMed Web of Science ®Google Scholar
• Hou, X., G. Liu, H. Zhang, H. Xiaofang, X. Zhang, F. Han, H. Cui, et al. 2020. “High-Mobility Group Box 1 Protein (HMGB1) from Cherry Valley Duck Mediates Signaling Pathways and Antiviral Activity.” Veterinary Research 51 (1): 1–15. BioMed Central. doi: 10.1186/s13567-020-00742-8.
   Google Scholar
• Hung, L. H., H. P. Li, Y. Y. Lien, M. L. Wu, and H. C. Chaung. 2010. “Adjuvant Effects of Chicken Interleukin-18 in Avian Newcastle Disease Vaccine.” Vaccine 28 (5): 1148–1155. doi:10.1016/j.vaccine.2009.11.042.
   Google Scholar
• Huo, S., Y. Zuo, L. Nan, L. Xiujin, Y. Zhang, L. Wang, H. Liu, et al. 2016. “Chicken IL-7 as a Potent Adjuvant Enhances IBDV VP2 DNA Vaccine Immunogenicity and Protective Efficacy.” Veterinary Microbiology 193: 145–155. Elsevier B.V. doi:10.1016/j.vetmic.2016.08.016.
   Google Scholar
• Huo, S., J. Zhang, J. Fan, X. Wang, W. Fengyang, Y. Zuo, and F. Zhong. 2019. “Co-Expression of Chicken Il-2 and Il-7 Enhances the Immunogenicity and Protective Efficacy of a Vp2-Expressing Dna Vaccine against IBDV in Chickens.” Viruses 11: 5. doi:10.3390/v11050476.
   Google Scholar
• Jafari M, Moghaddam Pour M, Taghizadeh M, Masoudi S and Bayat Z. (2017). Comparative assessment of humoral immune responses of aluminum hydroxide and oil-emulsion adjuvants in Influenza (H9N2) and Newcastle inactive vaccines to chickens. Artificial Cells, Nanomedicine, and Biotechnology, 45(1): 84–89. doi: 10.3109/21691401.2015.1129626
   PubMed Web of Science ®Google Scholar
• Kannaki, T. R., E. Priyanka, M. Abhilash, and S. Haunshi. 2021. “Co-Administration of Toll-like Receptor (TLR)-3 Agonist Poly I:C with Different Infectious Bursal Disease (IBD) Vaccines Improves IBD Specific Immune Response in Chicken.” Veterinary Research Communications 45 (4): 285–292. Springer Netherlands. doi:10.1007/s11259-021-09809-z.
   Google Scholar
• Kumar, S., Y. S. Ahi, S. S. Salunkhe, M. Koul, A. K. Tiwari, P. K. Gupta, and A. Rai. 2009. “Effective Protection by High Efficiency Bicistronic DNA Vaccine against Infectious Bursal Disease Virus Expressing VP2 Protein and Chicken IL-2.” Vaccine 27 (6): 864–869. doi:10.1016/j.vaccine.2008.11.085.
   Google Scholar
• Li, X., X. Yang, L. Liangwei, H. Liu, and J. Liu. 2006. “A Truncated C-Terminal Fragment of Mycobacterium Tuberculosis HSP70 Gene Enhanced Potency of HBV DNA Vaccine.” Vaccine 24 (16): 3321–3331. doi:10.1016/j.vaccine.2006.01.012.
   Google Scholar
• Li, L., and N. Petrovsky. 2017. “Molecular Adjuvants for DNA Vaccines.” Current Issues in Molecular Biology 22: 17–40. doi:10.21775/CIMB.022.017.
   PubMed Web of Science ®Google Scholar
• Lillehoj, H. S., W. Min, K. D. Choi, U. S. Babu, J. Burnside, T. Miyamoto, B. M. Rosenthal, and E. P. Lillehoj. 2001. “Molecular, Cellular, and Functional Characterization of Chicken Cytokines Homologous to Mammalian IL-15 and IL-2.” Veterinary Immunology and Immunopathology 82 (3–4): 229–244. doi:10.1016/S0165-2427(01)00360-9.
   Google Scholar
• Lin, S. Y., B. Y. Yao, C. M. Jack Hu, and H. W. Chen. 2020. “Induction of Robust Immune Responses by CpG-ODN-Loaded Hollow Polymeric Nanoparticles for Antiviral and Vaccine Applications in Chickens.” International Journal of Nanomedicine 15: 3303–3318. doi:10.2147/IJN.S241492.
   PubMed Web of Science ®Google Scholar
• Linde, A., C. R. Ross, E. G. Davis, L. Dib, F. Blecha, and T. Melgarejo. 2008. “Innate Immunity and Host Defense Peptides in Veterinary Medicine.” Journal of Veterinary Internal Medicine 22 (2): 247–265. John Wiley & Sons, Ltd. doi:10.1111/j.1939-1676.2007.0038.x.
   Google Scholar
• Liniger, M., A. Summerfield, N. Ruggli, and G. J. Renukaradhya. 2012. “MDA5 Can Be Exploited as Efficacious Genetic Adjuvant for DNA Vaccination against Lethal H5N1 Influenza Virus Infection in Chickens.” PLoS ONE 7: 12. doi:10.1371/journal.pone.0049952.
   Google Scholar
• López-Vidal, Y., S. P. De León-Rosales, M. Castañón-Arreola, M. S. Rangel-Frausto, E. Meléndez-Herrada, and E. Sada-Díaz. 2004. “Response of IFN-γ and IgG to ESAT-6 and 38 KDa Recombinant Proteins and Their Peptides from Mycobacterium Tuberculosis in Tuberculosis Patients and Asymptomatic Household Contacts May Indicate Possible Early-Stage Infection in the Latter.” Archives of Medical Research 35 (4): 308–317. doi:10.1016/j.arcmed.2004.04.008.
   Google Scholar
• Luzina, I. G., A. D. Keegan, N. M. Heller, G. A. W. Rook, T. Shea-Donohue, and S. P. Atamas. 2012. “Regulation of Inflammation by Interleukin-4: A Review of ‘Alternatives’.” Journal of Leukocyte Biology 92 (4): 753–764. John Wiley & Sons, Ltd. doi:10.1189/jlb.0412214.
   PubMed Web of Science ®Google Scholar
• Magee, C. N., O. Boenisch, and N. Najafian. 2012. “The Role of Costimulatory Molecules in Directing the Functional Differentiation of Alloreactive T Helper Cells.” American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 12 (10): 2588–2600. doi:10.1111/j.1600-6143.2012.04180.x.
   PubMed Web of Science ®Google Scholar
• Magor, K. E., D. M. Navarro, M. R. W. Barber, K. Petkau, X. Fleming-Canepa, G. A. D. Blyth, and A. H. Blaine. 2013. “Defense Genes Missing from the Flight Division.” Developmental and Comparative Immunology 41 (3): 377–388. Elsevier Ltd. doi:10.1016/j.dci.2013.04.010.
   PubMed Web of Science ®Google Scholar
• Maity, H. K., S. Dey, C. Madhan Mohan, S. A. Khulape, D. C. Pathak, and V. N. Vakharia. 2015. “Protective Efficacy of a DNA Vaccine Construct Encoding the VP2 Gene of Infectious Bursal Disease and a Truncated HSP70 of Mycobacterium Tuberculosis in Chickens.” Vaccine 33 (8): 1033–1039. Elsevier Ltd. doi:10.1016/j.vaccine.2015.01.006.
   Google Scholar
• Mallick, A. I., L. R. Payvand Parvizi, É. N. Read, S. Behboudi, and S. Sharif. 2011. “Enhancement of Immunogenicity of a Virosome-Based Avian Influenza Vaccine in Chickens by Incorporating CpG-ODN.” Vaccine 29 (8): 1657–1665. Elsevier Ltd. doi:10.1016/j.vaccine.2010.12.046.
   PubMed Web of Science ®Google Scholar
• Marijke, K. A., M. R. de Zoete, L. I. Bouwman, M. M. Vaezirad, P. M. Jos, and V. Putten. 2013. “Unique Features of Chicken Toll-like Receptors.” Developmental and Comparative Immunology 41 (3): 316–323. Elsevier Ltd. doi:10.1016/j.dci.2013.04.009.
   Google Scholar
• Metzger, D. W. 2010. “Interleukin-12 as an Adjuvant for Induction of Protective Antibody Responses.” Cytokine 52 (1–2): 102–107. Elsevier Ltd. doi:10.1016/j.cyto.2010.06.011.
   Google Scholar
• Miga, A., S. Masters, M. Gonzalez, and R. J. Noelle. 2000. “The Role of CD40-CD154 Interactions in the Regulation of Cell Mediated Immunity.” Immunological Investigations 29 (2): 111–114. Taylor & Francis. doi:10.3109/08820130009062292.
   PubMedGoogle Scholar
• Mogensen, T. H. 2009. “Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses.” Clinical Microbiology Reviews 22 (2): 240–273. doi:10.1128/CMR.00046-08.
   PubMed Web of Science ®Google Scholar
• Nawab, A., A. Lilong, W. Jiang, L. Guanghui, W. Liu, Y. Zhao, W. Qimin, and M. Xiao. 2019. “Chicken Toll-like Receptors and Their Significance in Immune Response and Disease Resistance.” International Reviews of Immunology 38 (6): 284–306. Taylor & Francis. doi:10.1080/08830185.2019.1659258.
   PubMed Web of Science ®Google Scholar
• Neerukonda, S. N., and U. Katneni. 2020. “Avian Pattern Recognition Receptor Sensing and Signaling.” Veterinary Sciences 7 (1): 1–41. doi:10.3390/vetsci7010014.
   Google Scholar
• Nonaka, M., and A. Kimura. 2006. “Genomic View of the Evolution of the Complement System.” Immunogenetics 58 (9): 701–713. doi:10.1007/s00251-006-0142-1.
   PubMed Web of Science ®Google Scholar
• Oveissi, S., A. R. Omar, K. Yusoff, F. Jahanshiri, and S. S. Hassan. 2010. “DNA Vaccine Encoding Avian Influenza Virus H5 and Esat-6 of Mycobacterium Tuberculosis Improved Antibody Responses against AIV in Chickens.” Comparative Immunology, Microbiology and Infectious Diseases 33 (6): 491–503. Elsevier Ltd. doi:10.1016/j.cimid.2009.08.004.
   Google Scholar
• Pasquale, A. D., S. Preiss, F. T. Da Silva, and N. Garçon. 2015. “Vaccine Adjuvants: From 1920 to 2015 and Beyond.” Vaccines 3 (2): 320–343. doi:10.3390/vaccines3020320.
   PubMed Web of Science ®Google Scholar
• Pfeffer, L. M., C. A. Dinarello, R. B. Herberman, R. G. Bryan, E. C. Williams, R. B. Borden, M. R. Walter, T. L. Nagabhushan, P. P. Trotta, and S. Pestka. 1998. “Biological Properties of Recombinant α-Interferons: 40th Anniversary of the Discovery of Interferons.” Cancer Research 58 (12): 2489–2499.
   Google Scholar
• Pose, A. G., J. N. Gómez, A. V. Sánchez, A. V. Redondo, E. R. Rodríguez, R. M. Seguí, E. M. González Ramos, et al. 2011. “Subunit Influenza Vaccine Candidate Based on CD154 Fused to HAH5 Increases the Antibody Titers and Cellular Immune Response in Chickens.” Veterinary Microbiology 152 (3–4): 328–337. doi:10.1016/j.vetmic.2011.05.033.
   Google Scholar
• Pulendran, B., E. Maraskovsky, J. Banchereau, and C. Maliszewski. 2001. “Modulating the Immune Response with Dendritic Cells and Their Growth Factors.” Trends in Immunology 22 (1): 41–47. doi:10.1016/S1471-4906(00)01794-4.
   Google Scholar
• Qiu, Y., Y. Shen, L. Xiangdong, C. Ding, and M. Zhiyong. 2008. “Molecular Cloning and Functional Characterization of a Novel Isoform of Chicken Myeloid Differentiation Factor 88 (MyD88).” Developmental and Comparative Immunology 32 (12): 1522–1530. doi:10.1016/j.dci.2008.05.016.
   PubMed Web of Science ®Google Scholar
• Rahman, M. M., E. Uyangaa, Y. W. Han, S. B. Kim, J. H. Kim, J. Y. Choi, and S. K. Eo. 2012. “Enhancement of Th1-Biased Protective Immunity against Avian Influenza H9N2 Virus via Oral Co-Administration of Attenuated Salmonella Enterica Serovar Typhimurium Expressing Chicken Interferon-α and Interleukin-18 along with an Inactivated Vaccine.” BMC Veterinary Research 8 (1): 105. doi:10.1186/1746-6148-8-105.
   Google Scholar
• Rahman, M. M., and S. K. Eo. 2012. “Prospects and Challenges of Using Chicken Cytokines in Disease Prevention.” Vaccine 30 (50): 7165–7173. Elsevier Ltd. doi:10.1016/j.vaccine.2012.10.011.
   Google Scholar
• Ramos, O. S., A. G. Pose, S. Gómez-Puerta, J. N. Gomez, A. V. Redondo, J. C. Águila Benites, L. S. Amarán, N. C. Parra, and J. R. Toledo Alonso. 2011. “Avian CD154 Enhances Humoral and Cellular Immune Responses Induced by an Adenovirus Vector-Based Vaccine in Chickens.” Comparative Immunology, Microbiology and Infectious Diseases 34 (3): 259–265. doi:10.1016/j.cimid.2010.12.001.
   Google Scholar
• Rohaim, M., H. Hussein, M. Iqbal, D. Santhakumar, M. Munir, and R. ElNaggar. 2018. “Chickens Expressing IFIT5 Ameliorate Clinical Outcome and Pathology of Highly Pathogenic Avian Influenza and Velogenic Newcastle Disease Viruses.” Frontiers in Immunology 9 (SEP). Frontiers Media S.A. doi:10.3389/fimmu.2018.02025.
   Google Scholar
• Ross, T. M., X. Yan, R. A. Bright, and H. L. Robinson. 2000. “C3d Enhancement of Antibodies to Hemagglutinin Accelerates Protection against Influenza Virus Challenge.” Nature Immunology 1 (2): 127–131. doi:10.1038/77802.
   PubMed Web of Science ®Google Scholar
• Roth, J. A. 2011. “Veterinary Vaccines and Their Importance to Animal Health and Public Health.” Procedia in Vaccinology 5: 127–136. doi:10.1016/j.provac.2011.10.009.
   PubMedGoogle Scholar
• Rus, H., C. Cudrici, and F. Niculescu. 2005. “The Role of the Complement System in Innate Immunity.” Immunologic Research 33 (2): 103–112. doi:10.1385/IR:33:2:.
   Google Scholar
• Sachan, S., S. Ramakrishnan, A. Annamalai, B. K. Sharma, B. C. Hina Malik, L. J. Saravanan, M. Saxena, A. Kumar, and N. Krishnaswamy. 2015. “Adjuvant Potential of Resiquimod with Inactivated Newcastle Disease Vaccine and Its Mechanism of Action in Chicken.” Vaccine 33 (36): 4526–4532. Elsevier Ltd. doi:10.1016/j.vaccine.2015.07.016.
   PubMed Web of Science ®Google Scholar
• Santhakumar, D., M. A. Mohsen Shahaat Rohaim, H. A. Hussein, P. Hawes, H. L. Ferreira, S. Behboudi, M. Iqbal, V. Nair, C. W. Arns, and M. Munir. 2018. “Chicken Interferon-Induced Protein with Tetratricopeptide Repeats 5 Antagonizes Replication of RNA Viruses.” Scientific Reports 8 (1): 1–20. doi:10.1038/s41598-018-24905-y.
   Google Scholar
• Sawant, P. M., P. C. Verma, P. K. Subudhi, U. Chaturvedi, M. Singh, R. Kumar, and A. K. Tiwari. 2011. “Immunomodulation of Bivalent Newcastle Disease DNA Vaccine Induced Immune Response by Co-Delivery of Chicken IFN-γ and IL-4 Genes.” Veterinary Immunology and Immunopathology 144 (1–2): 36–44. Elsevier B.V. doi:10.1016/j.vetimm.2011.07.006.
   PubMed Web of Science ®Google Scholar
• Sawant, P. M., K. Dhama, D. B. Rawool, M. Y. Wani, R. Tiwari, S. D. Singh, and R. K. Singh. 2015. “Development of a DNA Vaccine for Chicken Infectious Anemia and Its Immunogenicity Studies Using High Mobility Group Box 1 Protein as a Novel Immunoadjuvant Indicated Induction of Promising Protective Immune Responses.” Vaccine 33 (2): 333–340. Elsevier Ltd. doi:10.1016/j.vaccine.2014.11.020.
   Google Scholar
• Shao, Q., X. Wenpin, L. Yan, J. Liu, L. Rui, X. Xiao, Y. Xiaoxue, L. Yanan, and L. Zandong. 2014. “Function of Duck RIG-I in Induction of Antiviral Response against IBDV and Avian Influenza Virus on Chicken Cells.” Virus Research 191 (1): 184–191. Elsevier B.V. doi:10.1016/j.virusres.2014.07.028.
   Google Scholar
• Shen, S. Y., W. C. Chang, H. H. Yi, S. S. Tsai, H. J. Liu, P. C. Liao, and K. P. Chuang. 2015. “Development of a Subunit Vaccine Containing Recombinant Chicken Anemia Virus VP1 and Pigeon IFN-γ.” Veterinary Immunology and Immunopathology 167 (3–4): 200–204. Elsevier B.V. doi:10.1016/j.vetimm.2015.08.002.
   Google Scholar
• Shi, Y., C. H. Liu, A. I. Roberts, J. Das, X. Guangwu, G. Ren, Y. Zhang, et al. 2006. “Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) and T-Cell Responses: What We Do and Don’t Know.” Cell Research 16 (2): 126–133. doi:10.1038/sj.cr.7310017.
   PubMed Web of Science ®Google Scholar
• Shi, X.-M., Y. Zhao, H.-B. Gao, Z. Jing, M. Wang, H.-Y. Cui, G.-Z. Tong, and Y.-F. Wang. 2011. “Evaluation of Recombinant Fowlpox Virus Expressing Infectious Bronchitis Virus S1 Gene and Chicken Interferon- γ Gene for Immune Protection against Heterologous Strains.” Vaccine 29 (8): 1576–1582. Elsevier Ltd. doi:10.1016/j.vaccine.2010.12.102.
   Google Scholar
• Shi, S., H. Zhu, X. Xia, Z. Liang, M. Xuehu, and B. Sun. 2019. “Vaccine Adjuvants: Understanding the Structure and Mechanism of Adjuvanticity.” Vaccine 37 (24): 3167–3178. Elsevier Ltd. doi:10.1016/j.vaccine.2019.04.055.
   PubMed Web of Science ®Google Scholar
• Shtrichman, R., and C. E. Samuel. 2001. “The Role of Gamma Interferon in Antimicrobial Immunity.” Current Opinion in Microbiology 4 (3): 251–259. doi:10.1016/S1369-5274(00)00199-5.
   Google Scholar
• Singh, S. M., T. N. Alkie, É. Nagy, R. R. Kulkarni, D. C. Hodgins, and S. Sharif. 2016. “Delivery of an Inactivated Avian Influenza Virus Vaccine Adjuvanted with Poly(D,L-Lactic-Co-Glycolic Acid) Encapsulated CpG ODN Induces Protective Immune Responses in Chickens.” Vaccine 34 (40): 4807–4813. Elsevier Ltd. doi:10.1016/j.vaccine.2016.08.009.
   Google Scholar
• Sivakumar, S. M., M. M. Safhi, M. Kannadasan, and N. Sukumaran. 2011. “Vaccine Adjuvants - Current Status and Prospects on Controlled Release Adjuvancity.” Saudi Pharmaceutical Journal 19 (4): 197–206. King Saud University. doi:10.1016/j.jsps.2011.06.003.
   Google Scholar
• Spickler, A. R., and J. A. Roth. 2003. “Adjuvants in Veterinary Vaccines: Modes of Action and Adverse Effects.” Journal of Veterinary Internal Medicine 17 (3): 273–281. doi:10.1111/j.1939-1676.2003.tb02448.x.
   PubMed Web of Science ®Google Scholar
• Stills, H. F. 2005. “Adjuvants and Antibody Production: Dispelling the Myths Associated with Freund’s Complete and Other Adjuvants.” ILAR Journal 46 (3): 280–293. doi:10.1093/ilar.46.3.280.
   PubMed Web of Science ®Google Scholar
• Sun, B., X. Wang, J. Zhaoxia, L. Ruibin, and T. Xia. 2013. “NLRP3 Inflammasome Activation Induced by Engineered Nanomaterials.” Small 9 (9–10): 1595–1607. doi:10.1002/smll.201201962.
   PubMed Web of Science ®Google Scholar
• Sun, Y., N. Ding, S. Serena Ding, S. Yu, C. Meng, H. Chen, X. Qiu, et al. 2013. “Goose RIG-I Functions in Innate Immunity against Newcastle Disease Virus Infections.” Mol Immunol 53 (4): 321–327. doi:10.1016/j.molimm.2012.08.022.
   Google Scholar
• Suschak, J. J., J. A. Williams, and C. S. Schmaljohn. 2017. “Advancements in DNA Vaccine Vectors, Non-Mechanical Delivery Methods, and Molecular Adjuvants to Increase Immunogenicity.” Human Vaccines and Immunotherapeutics 13 (12): 2837–2848. Taylor & Francis. doi:10.1080/21645515.2017.1330236.
   PubMedGoogle Scholar
• Takeshita, F., T. Tanaka, T. Matsuda, M. Tozuka, K. Kobiyama, S. Saha, K. Matsui, et al. 2006. “Toll-Like Receptor Adaptor Molecules Enhance DNA-Raised Adaptive Immune Responses against Influenza and Tumors through Activation of Innate Immunity.” Journal of Virology 80 (13): 6218–6224. doi:10.1128/jvi.00121-06.
   Google Scholar
• Tan, B., H. Wang, L. Shang, and T. Yang. 2009. “Coadministration of Chicken GM-CSF with a DNA Vaccine Expressing Infectious Bronchitis Virus (IBV) S1 Glycoprotein Enhances the Specific Immune Response and Protects against IBV Infection.” Archives of Virology 154 (7): 1117–1124. doi:10.1007/s00705-009-0424-7.
   Google Scholar
• Tovey, M. G., and C. Lallemand. 2010. “Adjuvant Activity of Cytokines.” In Vaccine Adjuvants: Methods and Protocols, edited by, G. Davies, 287–309. Totowa, NJ: Humana Press. doi: 10.1007/978-1-60761-585-9_19.
   Google Scholar
• Tregaskes, C. A., H. L. Glansbeek, A. C. Gill, L. G. Hunt, J. Burnside, and J. R. Young. 2005. “Conservation of Biological Properties of the CD40 Ligand, CD154 in a Non-Mammalian Vertebrate.” Developmental and Comparative Immunology 29 (4): 361–374. doi:10.1016/j.dci.2004.09.001.
   Google Scholar
• Van Dijk, A., E. J. A. Veldhuizen, and H. P. Haagsman. 2008. “Avian Defensins.” Veterinary Immunology and Immunopathology 124 (1–2): 1–18. doi:10.1016/j.vetimm.2007.12.006.
   PubMed Web of Science ®Google Scholar
• Vogel, F. R. 2000. “Improving Vaccine Performance with Adjuvants.” Clinical Infectious Diseases 30 (SUPPL. 3): 266–270. doi:10.1086/313883.
   Google Scholar
• Wheaton, S., M. D. Lambourne, A. J. Sarson, J. T. Brisbin, A. Mayameei, and S. Sharif. 2007. “Molecular Cloning and Expression Analysis of Chicken MyD88 and TRIF Genes.” DNA Sequence - Journal of DNA Sequencing and Mapping 18 (6): 480–486. doi:10.1080/10425170701295856.
   Web of Science ®Google Scholar
• Wu, Z., and K. Liu. 2021. “Overview of Vaccine Adjuvants.” Medicine in Drug Discovery 11 (May): 100103. The Author(s). doi:10.1016/j.medidd.2021.100103.
   Google Scholar
• Xie, P., L. Yanling, L. Yaling, J. Liang, B. Xiang, Q. Lin, J. Jin, C. Ding, X. Chenggang, and T. Ren. 2020. “Immune Effect of a Newcastle Disease Virus DNA Vaccine with IL-12 as a Molecular Adjuvant Delivered by Electroporation.” Archives of Virology 165 (9): 1959–1968. Springer Vienna. doi:10.1007/s00705-020-04669-5.
   Google Scholar
• Xu, W., Q. Shao, Y. Zang, Q. Guo, Y. Zhang, and L. Zandong. 2015. “Pigeon RIG-I Function in Innate Immunity against H9N2 IAV and IBDV.” Viruses 7 (7): 4131–4151. MDPI AG. doi:10.3390/v7072813.
   Google Scholar
• Zeshan, B., M. H. Mushtaq, X. Wang, L. Wenliang, and P. Jiang. 2011. “Protective Immune Responses Induced by in Ovo Immunization with Recombinant Adenoviruses Expressing Spike (S1) Glycoprotein of Infectious Bronchitis Virus Fused/Co-Administered with Granulocyte-Macrophage Colony Stimulating Factor.” Veterinary Microbiology 148 (1): 8–17. Elsevier B.V. 10.1016/j.vetmic.2010.08.003.
   Google Scholar
• Zhang, H. H., X. M. Yang, Q. M. Xie, J. Y. Ma, Y. N. Luo, Y. C. Cao, F. Chen, and Y. Z. Bi. 2010a. “The Potent Adjuvant Effects of Chicken β-Defensin-1 When Genetically Fused with Infectious Bursal Disease Virus VP2 Gene.” Veterinary Immunology and Immunopathology 136 (1–2): 92–97. Elsevier B.V. doi:10.1016/j.vetimm.2010.02.018.
   Google Scholar
• Zhang, Z., L. Yongqing, X. Shufang, F. Chen, L. Zhang, B. Jiang, and X. Chen. 2010b. “Fusion to Chicken C3d Enhances the Immunogenicity of the M2 Protein of Avian Influenza Virus.” Virology Journal 7 (1): 1–11. doi:10.1186/1743-422X-7-89.
   Google Scholar
• Zhang, B., X. Liu, W. Chen, and L. Chen. 2013. “IFIT5 Potentiates Anti-Viral Response through Enhancing Innate Immune Signaling Pathways.” Acta Biochimica Et Biophysica Sinica 45 (10): 867–874. doi:10.1093/abbs/gmt088.
   Google Scholar
• Zhang, A., H. Lai, X. Jiahua, W. Huang, Y. Liu, D. Zhao, and R. Chen. 2017. “Evaluation of the Protective Efficacy of Poly I:C as an Adjuvant for H9N2 Subtype Avian Influenza Inactivated Vaccine and Its Mechanism of Action in Ducks.” PLoS ONE 12 (1): 2–13. doi:10.1371/journal.pone.0170681.
   Google Scholar
• Zhao, L., A. Seth, N. Wibowo, C. X. Zhao, N. Mitter, Y. Chengzhong, and A. P. J. Middelberg. 2014. “Nanoparticle Vaccines.” Vaccine 32 (3): 327–337. Elsevier Ltd. doi:10.1016/j.vaccine.2013.11.069.
   PubMed Web of Science ®Google Scholar
• Zhao, K., X. Duan, L. Hao, X. Wang, and Y. Wang. 2017. “Immune Effect of Newcastle Disease Virus DNA Vaccine with C3d as a Molecular Adjuvant.” Journal of Microbiology and Biotechnology 27 (11): 2060–2069. doi:10.4014/jmb.1708.08017.
   PubMed Web of Science ®Google Scholar